Odonate therapeutics, inc. (ODT)
CashFlow / Yearly
Dec'19Dec'18Dec'17
Cash flows from operating activities:
Net loss

-111,825

-88,960

-32,744

Adjustments to reconcile net loss to net cash used in operating activities:
Equity-based compensation expense

11,444

6,721

3,184

Depreciation and amortization

381

350

20

Non-cash contributions for expenses

-

64

1,812

Changes in operating assets and liabilities:
Prepaid expenses and other assets

2,936

-3,751

4,956

Accounts payable

4,782

6,392

3,642

Accrued expenses

1,516

4,155

3,184

Deferred rent

-

433

-

Net cash used in operating activities

-96,638

-67,094

-25,858

Purchases of property and equipment

166

1,907

83

Net cash used in investing activities

-166

-1,907

-83

Proceeds from issuance of common stock, net of issuance costs

135,096

9,848

221,447

Proceeds from issuance of common stock under employee stock plans

3,581

349

-

Net cash provided by financing activities

138,677

10,197

221,447

Net decrease in cash and restricted cash

41,873

-58,804

195,506

Supplemental disclosure of cash flow information:
Issuance costs included in accounts payable and accrued expenses

-

-

571

Property and equipment purchases included in accounts payable and accrued expenses

24

83

88

Initial recognition of right-of-use lease assets

2,215

-

-